The Patent Finder

Enmodulin, Inc.

Also on record
Records under this name other than the patents Enmodulin, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 6 of 6 · Back to Enmodulin, Inc.

PatentTitleStatus Expires Confidence
US 8,536,135Adaptive biochemical signatures
Lapsed on the fee record
Ended Sep 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 17, 2025From the USPTO record
US 7,371,813Method for Use of Igf-Binding Protein for Selective Sensitization of Target Cells in Vivo
Term ended
Ended no later than Nov 1, 2022 · Low confidence
Term endedEnded no later than Nov 1, 2022Low confidence
US 6,914,049IGF-binding protein-derived peptide or small molecule
Term ended
Term ended Oct 21, 2022 · From the USPTO record
Term endedTerm ended Oct 21, 2022From the USPTO record
US 6,861,406IGF-binding protein-derived peptide
Term ended
Term ended Aug 9, 2022 · From the USPTO record
Term endedTerm ended Aug 9, 2022From the USPTO record
US 7,611,893Metal-binding therapeutic peptides
Lapsed on the fee record
Ended Nov 3, 2017 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2017From the USPTO record
US 6,887,851IGF-binding protein-derived peptide
Lapsed on the fee record
Ended May 3, 2017 · From the USPTO record
Lapsed on the fee recordEnded May 3, 2017From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited